Understanding the genetic causes of pancreatic cancer

Core B: Human Pancreas

NIH-funded research Stanford University · NIH-10927312

This study is looking for patients with pancreatic cancer or chronic pancreatitis to share their tissue and blood samples, so researchers can learn more about the genetic factors behind pancreatic cancer and how the immune system affects it, ultimately helping to create better treatments.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-10927312 on NIH RePORTER

What this research studies

This research focuses on collecting and analyzing human pancreatic cancer tissues and blood samples to uncover the genetic factors that drive pancreatic cancer development. By establishing a bio-bank, the project aims to gather clinical and demographic information from patients with pancreatic cancer and chronic pancreatitis. The research will utilize advanced techniques such as histology and single-cell RNA sequencing to study the immune system's role in cancer progression. Patients may have the opportunity to contribute their samples, which will help in developing targeted therapies.

Who could benefit from this research

Good fit: Ideal candidates for participation include individuals diagnosed with pancreatic cancer or chronic pancreatitis who are willing to provide tissue and blood samples.

Not a fit: Patients with other types of cancer or those not diagnosed with pancreatic conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved early diagnosis and treatment options for pancreatic cancer patients.

How similar studies have performed: Previous research has shown success in using bio-banking and genetic analysis to enhance understanding of cancer, making this approach promising.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer GenesCancer Suppressor GenesCancer-Promoting Gene
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.